247 related articles for article (PubMed ID: 8151391)
1. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia.
Sinusas AJ; Shi Q; Saltzberg MT; Vitols P; Jain D; Wackers FJ; Zaret BL
J Nucl Med; 1994 Apr; 35(4):664-71. PubMed ID: 8151391
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-tetrofosmin assessment of myocardial perfusion and viability in canine models of coronary occlusion and reperfusion.
Glover DK; Ruiz M; Koplan BA; Watson DD; Beller GA
J Nucl Med; 1999 Jan; 40(1):142-9. PubMed ID: 9935070
[TBL] [Abstract][Full Text] [Related]
3. Myocardial 99mTc-tetrofosmin uptake during adenosine-induced vasodilatation with either a critical or mild coronary stenosis: comparison with 201Tl and regional myocardial blood flow.
Glover DK; Ruiz M; Yang JY; Smith WH; Watson DD; Beller GA
Circulation; 1997 Oct; 96(7):2332-8. PubMed ID: 9337208
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
[TBL] [Abstract][Full Text] [Related]
5. Flow versus uptake comparisons of thallium-201 with technetium-99m perfusion tracers in a canine model of myocardial ischemia.
Meleca MJ; McGoron AJ; Gerson MC; Millard RW; Gabel M; Biniakiewicz D; Roszell NJ; Walsh RA
J Nucl Med; 1997 Dec; 38(12):1847-56. PubMed ID: 9430457
[TBL] [Abstract][Full Text] [Related]
6. Myocardial uptake and kinetic properties of technetium-99m-Q3 in dogs.
Gerson MC; Millard RW; McGoron AJ; Gabel M; Washburn LC; Biniakiewicz D; Elder RC; Deutsch E; Walsh RA
J Nucl Med; 1994 Oct; 35(10):1698-706. PubMed ID: 7931674
[TBL] [Abstract][Full Text] [Related]
7. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
8. Comparison of microsphere-equivalent blood flow (15O-water PET) and relative perfusion (99mTc-tetrofosmin SPECT) in myocardium showing metabolism-perfusion mismatch.
Schaefer WM; Nowak B; Kaiser HJ; Koch KC; Block S; vom Dahl J; Buell U
J Nucl Med; 2003 Jan; 44(1):33-9. PubMed ID: 12515874
[TBL] [Abstract][Full Text] [Related]
9. Kinetic properties of 99mTc-Q12 in canine myocardium.
Gerson MC; Millard RW; Roszell NJ; McGoron AJ; Gabel M; Washburn LC; Biniakiewicz D; Blankenship D; Mallin WH; Elder RC
Circulation; 1994 Mar; 89(3):1291-300. PubMed ID: 8124818
[TBL] [Abstract][Full Text] [Related]
10. Limitations of dobutamine for enhancing flow heterogeneity in the presence of single coronary stenosis: implications for technetium-99m-sestamibi imaging.
Wu JC; Yun JJ; Heller EN; Dione DP; DeMan P; Liu YH; Zaret BL; Wackers FJ; Sinusas AJ
J Nucl Med; 1998 Mar; 39(3):417-25. PubMed ID: 9529285
[TBL] [Abstract][Full Text] [Related]
11. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction.
Koplan BA; Beller GA; Ruiz M; Yang JY; Watson DD; Glover DK
J Nucl Med; 1996 Aug; 37(8):1398-402. PubMed ID: 8708783
[TBL] [Abstract][Full Text] [Related]
12. Organ biodistribution and myocardial uptake, washout, and redistribution kinetics of Tc-99m N-DBODC5 when injected during vasodilator stress in canine models of coronary stenoses.
Hatada K; Ruiz M; Riou LM; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Cardiol; 2006 Nov; 13(6):779-90. PubMed ID: 17174809
[TBL] [Abstract][Full Text] [Related]
13. Planar imaging of 99mTc-labeled (bis(N-ethoxy, N-ethyl dithiocarbamato) nitrido technetium[V]) can detect resting ischemia.
Johnson G; Nguyen KN; Liu Z; Gao P; Pasqualini R; Okada RD
J Nucl Cardiol; 1997; 4(3):217-25. PubMed ID: 9199259
[TBL] [Abstract][Full Text] [Related]
14. Redistribution of 99mTc-sestamibi and 201Tl in the presence of a severe coronary artery stenosis.
Sinusas AJ; Bergin JD; Edwards NC; Watson DD; Ruiz M; Makuch RW; Smith WH; Beller GA
Circulation; 1994 May; 89(5):2332-41. PubMed ID: 8181159
[TBL] [Abstract][Full Text] [Related]
15. Experimental verification of technetium 99m-labeled teboroxime kinetic parameters in the myocardium with dynamic single-photon emission computed tomography: reproducibility, correlation to flow, and susceptibility to extravascular contamination.
Smith AM; Gullberg GT; Christian PE
J Nucl Cardiol; 1996; 3(2):130-42. PubMed ID: 8799238
[TBL] [Abstract][Full Text] [Related]
16. Verapamil does not inhibit 99mTcN-NOET uptake in situ in normal or ischemic canine myocardium.
Riou LM; Ghezzi C; Vanzetto G; Broisat A; Mathieu JP; Bontron R; Pasqualini R; Fagret D
J Nucl Med; 2003 Jun; 44(6):981-7. PubMed ID: 12791829
[TBL] [Abstract][Full Text] [Related]
17. Assessment of severity of coronary artery stenosis in a canine model using the PET agent 18F-fluorobenzyl triphenyl phosphonium: comparison with 99mTc-tetrofosmin.
Madar I; Ravert H; Dipaula A; Du Y; Dannals RF; Becker L
J Nucl Med; 2007 Jun; 48(6):1021-30. PubMed ID: 17504876
[TBL] [Abstract][Full Text] [Related]
18. Monocationic radiotracer kinetics and myocardial infarct size: a perfused rat heart study.
Okada DR; Liu Z; Beju D; Okada RD; Johnson G
Ann Nucl Med; 2008 Aug; 22(7):617-27. PubMed ID: 18756365
[TBL] [Abstract][Full Text] [Related]
19. Comparison of sestamibi, tetrofosmin, and Q12 retention in porcine myocardium.
Matsunari I; Haas F; Nguyen NT; Reidel G; Wolf I; Senekowitsch-Schmidtke R; Stöcklin G; Schwaiger M
J Nucl Med; 2001 May; 42(5):818-23. PubMed ID: 11337582
[TBL] [Abstract][Full Text] [Related]
20. Myocardial tomography with technetium-99m-tetrofosmin during intravenous infusion of adenosine triphosphate.
Takeishi Y; Takahashi N; Fujiwara S; Atsumi H; Takahashi K; Tomoike H
J Nucl Med; 1998 Apr; 39(4):582-6. PubMed ID: 9544660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
